Hookipa pharma reports q4 loss per share of $0.40

Hookipa pharma reports fourth quarter and full year 2019 financial results and provides a corporate update.q4 revenue $3.6 million versus refinitiv ibes estimate of $2.9 million.qtrly loss per share $0.40.q4 earnings per share view $-0.47 -- refinitiv ibes data.

SY Ratings Summary

SY Quant Ranking